Dignify Therapeutics
Developer of novel drug therapies intended to restore voluntary control of excretory function to neurologically impaired people. The company provides effective and convenient pharmaceutical agents that trigger the voiding of bladder and bowel contents when the person wishes, enabling patients with spinal cord injury, spina bifida, and other neurological conditions to have an enhanced way of life.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
14
11 to 50 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
1
tools in use
Monthly traffic
106
organic / mo
Sign up free to see all 5 verified contacts at Dignify Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- JW
Jeff Welch
& () · Other
EmailPhone - KT
Karl Thor
Chief Scientific Officer · Research & Development
EmailPhone - MA
Mary A Katofiasc
Director of Operations · Operations
EmailPhone - DR
Dan Ricca
VP, Chemistry · Science
EmailPhone
Showing 4 of 5 verified contacts
Top roles at Dignify Therapeutics
4 distinct titles indexed · top 4 shown.
- 1& ()
- 1chief scientific officer
- 1director of operations
- 1vp, chemistry
Sign up to unlock all 5 contacts at Dignify Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Dignify Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.